Company profile

Vaxcyte Tech Stack

Clinical-stage pneumococcal conjugate vaccine developer preparing for commercial launch

Biotechnology Research San Carlos, California 501–1,000 employees Founded 2013 Public Company

Vaxcyte develops broad-spectrum pneumococcal conjugate vaccines built on a cell-free protein synthesis platform. Its stack pairs a validated GxP layer (Veeva Vault QMS and QualityDocs, LIMS, Benchling, Chromeleon) with SAP S/4HANA, SAP SCM and master data tooling, a commercial-grade ERP footprint. Senior- and director-heavy hiring across engineering, manufacturing and research, plus recurring BLA and launch-readiness themes, signal a shift from clinical development toward commercialization.

Tech Stack 27 technologies

Core StackNext.js React GraphQL Playwright Cypress SAP Smartsheet SAP S/4HANA JMP HPLC LIMS Veeva SAP Master Data Management Veeva Vault LC-MS SAP SCM SDS-PAGE GC-MS Azure Ironclad CMMS Veeva QualityDocs Chromeleon Veeva QMS Benchling Tecan

What Vaxcyte Is BuildingChallenges and projects from their job posts

◆Challenges

Commercial launch readiness
Regulatory filings and facility readiness for BLA
Maintaining supply continuity
Complex biologics development
Ensuring strong safety surveillance
Enhancing compliance workflows

▲Active Projects

Technology transfer
Process validation execution
Technical launch planning
Conjugation process development for pipeline programs
Analytical method development and qualification for vaccines
CDC immunization program integration

Hiring Activity

Decelerating50 roles · 7 in 30d

Department

Engineering

Manufacturing

Research

Ops

Product

Data

Legal

Quality

Seniority

Senior

Director

Mid

Manager

Staff

Intern

Notable leadership hires: Analytical Technical Lead

Companies like Vaxcyte

100+ Biotechnology Research companies running HPLC and LIMS

See the full list

About Vaxcyte

Vaxcyte is a public vaccine company headquartered in San Carlos, California, founded in 2013 and employing 501–1,000 people. It develops pneumococcal conjugate vaccine candidates aimed at preventing invasive pneumococcal disease, with VAX-31 in adult and infant clinical programs, VAX-24 targeting infants, and the earlier-stage VAX-XL. Its approach combines site-specific conjugation with a licensed cell-free protein synthesis system for producing hard-to-make antigens. Hiring is concentrated in the United States across engineering, manufacturing, research, operations and quality functions.

HeadquartersSan Carlos, California

Company Size501–1,000 employees

Founded2013

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Vaxcyte use?

Vaxcyte runs SAP S/4HANA, SAP SCM and SAP Master Data Management alongside Veeva Vault, Veeva QMS, Benchling, LIMS, JMP and Smartsheet, plus lab systems such as HPLC, LC-MS, Chromeleon and Tecan, on Azure.

What is Vaxcyte working on?

Job posts point to technology transfer, process validation, conjugation process development, analytical method development for vaccine programs, stability programs and technical launch planning.

Where is Vaxcyte headquartered?

Vaxcyte is headquartered in San Carlos, California, and currently hires in the United States, with demand concentrated in engineering, manufacturing and research roles.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

Ionis Pharmaceuticals, Inc.

Biotechnology Research

PSC Biotech® Corporation

Biotechnology Research

insitro

Biotechnology Research

Praxis Precision Medicines, Inc.

Biotechnology Research

How this profile is built

Vaxcyte's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.